Skip to main content
Clinical Trials/NCT00799474
NCT00799474
Completed
Not Applicable

Men's Beliefs About Associations Between HPV, Cancers, and HPV Vaccination

University of North Carolina, Chapel Hill0 sites609 target enrollmentDecember 2008
ConditionsAnus Neoplasms

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Anus Neoplasms
Sponsor
University of North Carolina, Chapel Hill
Enrollment
609
Primary Endpoint
Willingness to Receive the Human Papillomavirus (HPV) Vaccine
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

This research focuses on men who have sex with men (MSM) who are at higher risk of anal cancer. The survey will evaluate their beliefs about anal and oral cancer, their knowledge about role of human papillomavirus (HPV) infection in these cancers, and their knowledge of HPV vaccination and anal Pap smears. Approximately 12% of subjects will be HIV-positive.

Detailed Description

Little research has examined men's understanding of what causes anal and oral cancers and whether HPV vaccination can play a potential protective role. This research focuses on men who have sex with men (MSM) who are at notably elevated risk of anal cancer, and seeks to characterize their beliefs about anal and oral cancer, knowledge about the etiological role of HPV infection in these cancers, as well as their knowledge of HPV vaccination and anal Pap smears. We will also study heterosexual men.

Registry
clinicaltrials.gov
Start Date
December 2008
End Date
January 2009
Last Updated
10 years ago
Study Type
Observational
Sex
Male

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • aged 18-59
  • answered question about sexual orientation

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Willingness to Receive the Human Papillomavirus (HPV) Vaccine

Time Frame: at time of interview

Measured participants' willingness to receive HPV vaccine. Participants were asked how willing they would be to get HPV vaccine if it were approved for use in males. A 5-point scale ranging from "definitely not willing" to "definitely willing" was used to meausure willingness.

Secondary Outcomes

  • Knowledge of HPV(At time of interview)
  • Awareness of HPV Vaccine(At time of interview)

Similar Trials